NCT06673953

Brief Summary

The purpose of this study is to investigate if there is any effect of the respiratory training on cardiopulmonary functions in patients with upper cross syndrome post-cardiac surgery. Hypothesis: Null hypothesis: There is no effect of the respiratory training on pulmonary functions in patients with upper cross syndrome post-cardiac surgery.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Aug 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 28, 2024

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

November 1, 2024

Completed
4 days until next milestone

First Posted

Study publicly available on registry

November 5, 2024

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 20, 2025

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

February 25, 2025

Completed
Last Updated

November 5, 2024

Status Verified

November 1, 2024

Enrollment Period

5 months

First QC Date

November 1, 2024

Last Update Submit

November 2, 2024

Conditions

Keywords

Post-CABG / Upper Cross Syndrome / Respiratory Muscle Training

Outcome Measures

Primary Outcomes (9)

  • Pulmonary functions:

    Measurements of ventilatory function are recorded before and after receiving the treatment sessions (FEV1, FVC, FEV1/FVC, MVV). Assessing respiratory improvement. Unit of Measure: Liters (L)

    Baseline (assessment), and at 12 weeks post-intervention.

  • Six-Minute-Walk Test

    Patients are asked to walk for 6 minutes along a flat corridor. Measured in meters, assessing exercise capacity and functional improvement. The SpO2 and heart rate are measured continuously during testing. Heart Rate (HR): Measured in beats per minute (BPM), evaluating cardiovascular response. SpO2 (Peripheral Oxygen Saturation): Assessing: Blood oxygen saturation levels to evaluate respiratory and cardiovascular efficiency. Unit of Measure: Percentage (%)

    Baseline (assessment), and at 12 weeks post-intervention.

  • VO2 max (Maximal Oxygen Consumption)

    Assessing: Maximum oxygen uptake during high-intensity exercise to evaluate aerobic capacity and cardiopulmonary function. Estimated based on an equation which contains: weight is body weight (kg), 6MWD is distance walked in 6 min (m), age (years), BMI is calculated body mass index(kg/m2), height is body height (cm) and HR is heart rate at the end of the walking test. Unit of Measure: mL/kg/min

    Baseline (assessment), and at 12 weeks post-intervention.

  • Pittsburgh Sleep Quality Index.

    Respondents are asked to indicate how frequently they have experienced certain sleep difficulties and rate them. Scores for each question range from 0 to 3, with higher scores indicating more acute sleep disturbances.

    Baseline (assessment), and at 12 weeks post-intervention.

  • Short Form 36 (SF-36) Health Survey Questionnaire (Arabic version).

    A 36-item scale measures eight domains of health status. The scores are transformed to range from zero where the respondent has the worst possible health to 100 where the respondent is in the best possible health.

    Baseline (assessment), and at 12 weeks post-intervention.

  • Pain severity

    Assessing intensity of perceived pain for monitoring changes in pain severity throughout the intervention. Pain severity is assessed by the self-reported Visual Analog Scale (VAS). By using a 10 cm line where patients mark their pain level, with 0 representing "no pain" and 10 representing "worst imaginable pain." Unit of Measure: Points on a 0-10 scale

    Baseline (assessment), and at 12 weeks post-intervention.

  • Endurance of DCF

    Endurance of DCF muscles is measured by a pressure biofeedback instrument. The patient lays in the crook lying position and the pressure biofeedback instrument is placed under the neutral cervical spine below the occiput and inflated up to 20 mmHg. The subjects perform this movement at 5 different pressure levels, i.e., 22, 24, 26, 28, and 30 mmHg. Each level is supposed to be held for 10 sec, and the test terminated if they are unable to hold the position for 10 sec at any level or if the maximum level is achieved (30 mmHg).

    Baseline (assessment), and at 12 weeks post-intervention.

  • Craniovertebral angle measurement

    Adhesive markers are placed on the tragus of the right ear and the C7 spinous process, and the subjects are instructed to stand by side (lateral view) and to look at a target in front of them with both arms beside the body. Then, a digital camera is fixed at the level of the 7th cervical vertebra. Finally, the Surgi map Spine software is used to analyze the digitalized photographs and measure CVA. It is the angle between 2 imaginary lines: the horizontal line passing through the spinous process of C7 and the line passing from C7 to the tragus of the ear.

    Baseline (assessment), and at 12 weeks post-intervention.

  • Weight and height measurement

    Weight and height are recorded, and BMI will be calculated according to the formula: BMI = Weight (Kg) / Height (m2)

    Baseline (assessment)

Study Arms (2)

Respiratory training (study) group.

EXPERIMENTAL

Thirty patients (n=30) receiving respiratory muscles training and traditional physical therapy program for six weeks (three sessions/ week) for 40-60 minutes.

Other: Respiratory Muscle Training by (The Breather)Other: Traditional physical therapy program

Traditional (control) group

ACTIVE COMPARATOR

Thirty patients (n=30) receiving the traditional physical therapy program for six weeks (three sessions/ week) for 40-60 minutes.

Other: Traditional physical therapy program

Interventions

Patients are instructed to inhale deeply and forcefully (at non fatigable resistance) for 2-3 seconds, slight pause, and then exhale forcefully for 2-3 seconds for 10 repetitions with 2 sets.

Also known as: Respiratory Muscle Training
Respiratory training (study) group.

Traditional physical therapy program in form of: (TENS / Low-intensity continuous ultrasonic / Infrared radiation application / Cervical Stabilization exercise )

Also known as: Conventional physical therapy program
Respiratory training (study) group.Traditional (control) group

Eligibility Criteria

Age45 Years - 55 Years
Sexmale(Gender-based eligibility)
Gender Eligibility DetailsMale
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Sixty post-CABG-male-patients for at least three months and their age ranges from 45 to 55 years old.
  • Craniovertebral angle \< 51°, but not less than 30°.
  • Non-specific chronic neck pain: defined as neck pain without an identifiable pathological cause and attributed to poor posture without radiation to upper limbs.
  • VAS score between 3-7.
  • Their body mass index ranges from (25 -29.9) kg/m2.
  • Values of FEV1 and FVC lower than 80%

You may not qualify if:

  • Rheumatoid arthritis, cervical disc pathology, and traumatic neck pain.
  • History of respiratory disease and clinical signs of severe cardiac events.
  • Neurological disorders which affect the diaphragm.
  • Patients whose BMI is less than 25, or greater than 30 kg/m2.
  • Smokers.
  • Values of FEV1 and FVC higher than 80%
  • Patients with chronic obstructive pulmonary disease or asthma.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Faculty of Physical Therapy, Cairo University

Giza, Giza Governorate, 11432, Egypt

RECRUITING

MeSH Terms

Conditions

Oculocerebral hypopigmentation syndrome type Preus

Interventions

Breathing Exercises

Intervention Hierarchy (Ancestors)

Mind-Body TherapiesComplementary TherapiesTherapeuticsExercise Movement TechniquesPhysical Therapy Modalities

Study Officials

  • Zeinab Helmy, Professor

    Professor of Physical Therapy for Cardiovascular / Respiratory Disorder and Geriatrics. Faculty of Physical Therapy. Cairo University

    STUDY CHAIR
  • El-Sayed Felaya, Lecturer

    Lecturer of Physical Therapy for Cardiovascular / Respiratory Disorder and Geriatrics. Faculty of Physical Therapy. Cairo University

    STUDY DIRECTOR
  • Ahmed Elsisi, Assistant Professor

    Assistant Professor of Critical Care Medicine. Faculty of Medicine. Beni suef University

    STUDY DIRECTOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Lecturer

Study Record Dates

First Submitted

November 1, 2024

First Posted

November 5, 2024

Study Start

August 28, 2024

Primary Completion

January 20, 2025

Study Completion

February 25, 2025

Last Updated

November 5, 2024

Record last verified: 2024-11

Locations